Devices and technology

Completing a brief, adaptive questionnaire prior to each consultation with healthcare providers can focus discussions toward the immediate priorities and concerns of people with diabetes, shows a feasibility study.

A type 1 diabetes outpatient model in which patients decide the frequency and timing of their own appointments was well received and did not affect clinical outcomes in the DIATAST randomized controlled trial.

Although helpful for primary care physicians, a type 2 diabetes treatment decision support tool may be missing the point for most people with poorly controlled glucose levels, suggest findings from a pilot study.

Giving people with type 2 diabetes “wear-and-forget” masked flash glucose monitoring to allow their healthcare providers access to detailed glucose profiles is feasible in primary care, but it is not clear how beneficial this is, show the results of the GP-OSMOTIC trial.

medwireNews talks to one of the pioneers of closed-loop insulin delivery, Roman Hovorka, about his algorithm, his research so far, and his plans for commercialization.

Researchers show that closed-loop insulin delivery achieves markedly better glucose control than standard insulin management in hospitalized patients with hyperglycemia receiving enteral or parenteral nutrition.

Ophthalmologist Philip Burgess joins Clinical Diabetologist John Wilding to discuss diabetic retinopathy screening and the key role that it plays in reducing vision loss among people with diabetes (10:00).

With the use of insulin pumps and related technologies expected to increase among pregnant women with type 1 diabetes, Pratik Choudhary and Lori Berard discuss management protocols for women admitted to maternity units (4:26).

Pratik Choudhary and Lori Berard discuss considerations for treating diabetes device users admitted for surgical procedures and radiological investigations (11:41).

Lori Berard and Pratik Choudhary address situations that can lead to emergency department admissions in patients using diabetes devices and discuss management strategies tailored to this patient population (9:36).

Lori Berard and Pratik Choudhary address situations that can lead to hospital admissions in insulin pump users, and discuss what the treating clinician needs to know (8:42).

Diabetologist Pratik Choudhary and Nurse Consultant Lori Berard discuss inpatient use of continuous glucose monitoring (CGM) devices and insulin dosing apps (8:14).

Satyarengga M, Siddiqui T, Spanakis EK. Curr Diab Rep 2018; 18: 87. doi: 10.1007/s11892-018-1067-4

Thompson B et al. Curr Diab Rep 2018; 18: 81. doi: 10.1007/s11892-018-1056-7

Khowaja A et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0468-3

Gregory NS et al. Curr Diab Rep 2018; 18: 54. doi: 10.1007/s11892-018-1027-z

Ronda MCM et al. BMC Fam Pract 2018; 19: 94. doi: 10.1186/s12875-018-0781-y

Everett E, Mathioudakis N. Curr Diab Rep 2018; 18: 49. doi: 10.1007/s11892-018-1026-0

Fully closed-loop insulin delivery results in a markedly improved time in range among inpatients with type 2 diabetes receiving noncritical care, researchers have reported.

Rasekaba TM et al. Diabetes Res Clin Prac 2018; 142: 276–285. doi: 10.1016/j.diabres.2018.05.049